Skip to content
Nonprofiteer
← All organizations

LIFESPAN RESEARCH INSTITUTION

EIN 94-3473864 MOUNTAIN VIEW, CA

Revenue 2024
$1,799,122
Expenses 2024
$6,520,518

Program services were 70.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

As filed

Subsection
03
NTEE code
H92
Classification
1000
Street
319 BERNARDO AVE

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2024

Mission

Lifespan Research Institute ("LRI") is a 501(c)(3) nonprofit organization focused on the defeat of age-related disease and the extension of healthy human lifespan through raising funds and awareness for scientific work addressing the root causes of the aging process, building a thriving ecosystem of mission aligned stakeholders which can be mobilized to strategic action, and spearheading relevant research projects directly. We work to identify, develop, and promote initiatives with outsized impact and the greatest potential to realize widespread access to regenerative medicine solutions targeting the disabilities and diseases of aging.

Activities or mission (Part I)

Develop, promote and ensure widespread access to rejuvenation biotechnologies.

  • The research program is carried out both in the Organization's Mountain View facility by employees of the Organization and at some of the most prestigious institutions around the world. The program is comprised of both internal and external research programs. There are currently two (2) separate lines of internal research: Mitochondrial mutations and Immuno-senescence. The Mitochondrial mutations line of research has published work and contains four (4) subprojects, some of which involve collaborations with outside institutions. The Immuno-senescence line of research has also published work and contains nine (9) subprojects, also involving collaborations with outside institutions. There are currently two (2) external research projects ongoing at outside institutions. Funding for these programs continue to be prioritized for projects that meet our company mission and are currently being unaddressed in our intramural research program.

    Expenses $3,105,866 · Grants $109,824

  • Education - As part of its mission, the Organization is committed to educating students and the public about rejuvenation biotechnologies. The Organization's student program, Education, is committed to educating students and the public. Education operates a summer internship program that places twelve (12) undergraduate students at the Research Center and outside institutions. It also continues a program to place nine (9) post-baccalaureate students at various institutions, including four (4) at the SRF Research Center. 2022 saw the expansion of SRF's Master's program in conjunction with Dominican University of California and the formation of a new graduate internship program to host graduate students from other institutions. SRF now has had one (1) Master's student graduate from the Master's program in 2023, has successfully hosted two (2) graduate interns in the past, and is currently hosting one (1) new graduate intern who joined in 2024.

    Expenses $868,809 · Grants $72,867 · Revenue $12,000

  • Marketing/Media - In addition to participation in a variety of scientific and public engagements, the Organization organizes its own virtual marketing campaigns, conferences, and events. This outreach is intended to inform both the scientific community and the public about the field of rejuvenation biotechnology. The Organization paused conferences in 2024 and 2025 due to the merger but plans to resume in-person conferences in 2026.

    Expenses $498,310 · Revenue $60,805

  • Longevity Investor Network As part of the Organization's mission to build an ecosystem of aligned stakeholders, LRI's investor network catalyzes private investment in biotechnology companies developing interventions that target the root mechanisms of aging. In 2024, the Organization hosted a successful Longevity Investor Network event in San Francisco, bringing together start-ups and investors within the rejuvenation biotechnology field. In addition, the LIN hosts weekly virtual pitch sessions at which start-ups present their companies to a group of investors. Lifespan News As part of the Organization's mission to inform the public about the latest news in the longevity biotech field, LRI hosts its own news outlet with weekly articles about the latest publications and breakthroughs in the field.

    Expenses $119,819 · Revenue $6,931

  • Other programs - The Organization conducts other programs related to the mission of the organization.

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

  • Keith Comito Started 10124

    President

    Total calculated
    $0
    Hours/week
    40
  • Oliver Medvedik Started 10124

    Secretary

    Total calculated
    $0
    Hours/week
    40
  • Paul Spiegel Started 10124

    Chairman of the Board

    Total calculated
    $0
    Hours/week
    1
  • Andrew Aiello Started 10124

    Treasurer

    Total calculated
    $0
    Hours/week
    5
  • Kevin Dewalt

    Board Member

    Total calculated
    $0
    Hours/week
    1
  • Barbara Logan

    Board Member

    Total calculated
    $0
    Hours/week
    1
  • Kevin Perrott Terminated 122724

    Treasurer and Secretary

    Total calculated
    $0
    Hours/week
    5
  • Bill Lao

    Chairman of the Board

    Total calculated
    $0
    Hours/week
    5
  • Lisa Fabiny-Kiser

    Chief Executive Officer

    Total calculated
    $292,427
    From this org
    $230,054
    From related orgs
    $0
    Other
    $62,373
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $230,054
    Bonus
    $0
    Other
    $0
    Deferred
    $9,600
    Nontaxable benefits
    $52,773
    Filer's total
    $292,427
  • Stephanie Dainow

    Chief Business Officer

    Total calculated
    $188,564
    From this org
    $179,056
    From related orgs
    $0
    Other
    $9,508
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $179,056
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $9,508
    Filer's total
    $188,564
  • Maria Entraigues Abramson

    Director of Development

    Total calculated
    $173,108
    From this org
    $146,296
    From related orgs
    $0
    Other
    $26,812
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $146,296
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $26,812
    Filer's total
    $173,108
  • Emily Lillian Fishman

    Director of Education

    Total calculated
    $166,834
    From this org
    $145,710
    From related orgs
    $0
    Other
    $21,124
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $145,710
    Bonus
    $0
    Other
    $0
    Deferred
    $5,984
    Nontaxable benefits
    $15,140
    Filer's total
    $166,834
  • Miguel Moreno-Garcia Terminated 102

    Director of Research

    Total calculated
    $179,573
    From this org
    $145,702
    From related orgs
    $0
    Other
    $33,871
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $145,702
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $33,871
    Filer's total
    $179,573
  • Kelly Boemmel

    Director of Operations

    Total calculated
    $164,168
    From this org
    $144,900
    From related orgs
    $0
    Other
    $19,268
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $144,900
    Bonus
    $0
    Other
    $0
    Deferred
    $5,916
    Nontaxable benefits
    $13,352
    Filer's total
    $164,168

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

  • 2024
    Revenue
    $1,799,122
    Expenses
    $6,520,518
    Contributions
    $419,258
    Grants paid
    $182,691
  • 2023
    Revenue
    $814,560
    Expenses
    $7,533,214
    Contributions
    $348,261
    Grants paid
    $1,573,325
  • 2022
    Revenue
    $1,314,297
    Expenses
    $7,587,528
    Contributions
    $1,205,845
    Grants paid
    $1,556,290

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

  • 2024 · 990-T

    Revenue
    not reported
    Expenses
    not reported
    Assets (EOY)
    not reported
  • 2022 · 990-T

    Revenue
    not reported
    Expenses
    not reported
    Assets (EOY)
    not reported
  • 2021 · 990

    Revenue
    $30,218,866
    Expenses
    $7,523,180
    Assets (EOY)
    $28,441,155
  • 2021 · 990

    Revenue
    $30,218,866
    Expenses
    $5,523,180
    Assets (EOY)
    $28,441,155
  • 2021 · 990-T

    Revenue
    not reported
    Expenses
    not reported
    Assets (EOY)
    not reported
  • 2020 · 990

    Revenue
    $4,002,442
    Expenses
    $4,070,101
    Assets (EOY)
    $3,998,305
  • 2020 · 990-T

    Revenue
    not reported
    Expenses
    not reported
    Assets (EOY)
    not reported
  • 2019 · 990

    Revenue
    $2,656,250
    Expenses
    $4,481,205
    Assets (EOY)
    $3,932,519
  • 2018 · 990

    Revenue
    $2,436,573
    Expenses
    $3,568,259
    Assets (EOY)
    $5,306,491
  • 2017 · 990

    Revenue
    $7,871,339
    Expenses
    $3,925,675
    Assets (EOY)
    $6,675,404

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.

Grants made

The 10 largest by cash amount. The API serves every itemized grant.

Where these grants went next →

Grants received

The 10 largest by cash amount. The API serves every itemized grant.

Other IRS files

Auto-Revocation List

Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.

Publication 78

Listed as of 13 October 2026, under deductibility PC.

These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.

What this page reflects

The registration facts above come from the IRS Business Master File published 13 October 2026 and read 26 October 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.